Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FKEFG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,441
Award facts
- Contract value 100% obligated
- $16,441.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,441.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Stelara 90 mg/ml syringes on April 24, 2025, with an ultimate completion date of May 15, 2025. No set-aside designation was used for this award. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the prime contractor. Stelara is a biologic medication used to treat various autoimmune conditions, and this delivery order represents a specific pharmaceutical supply need for federal healthcare facilities.
This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This master contract enables the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently securing contracts for branded and generic prescription drugs, biologics, and medical consumables across multiple therapeutic categories including oncology treatments, vaccines, and specialty medications.
Quick answers
Who was awarded contract SPE2DB25FKEFG?
SPE2DB25FKEFG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FKEFG worth?
The government has obligated $16,441 on SPE2DB25FKEFG.
Is contract SPE2DB25FKEFG an order under another contract?
Yes. SPE2DB25FKEFG is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEFG competed?
The extent of competition for SPE2DB25FKEFG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award